文献速递胰腺与胆道疾病

检测抗PBP抗体对诊断自身免疫性胰腺炎没有帮助

Testing for Anti-PBP Antibody Is Not Useful in Diagnosing Autoimmune Pancreatitis.
PubMed 文献 · Am J Gastroenterol · 2016-06-21

本研究旨在验证2009年报道的抗幽门螺杆菌纤溶酶原结合蛋白(PBP)抗体诊断自身免疫性胰腺炎(AIP)的性能。2007年3月至2011年5月连续收集1型AIP、胰腺导管腺癌、慢性胰腺炎、原发性硬化性胆管炎及健康对照血清,用ELISA法检测抗PBP肽抗体,结果各组间无显著差异,提示该抗体不是诊断AIP的有用工具。

要点

  • 采用敏感且特异的ELISA法检测抗PBP肽抗体,各组与健康对照间无显著差异。
  • AIP患者血清中未发现抗PBP肽抗体升高。
  • 抗PBP血清抗体不是诊断AIP的有用工具。

核心结论

  • 使用敏感且特异的ELISA法,未发现AIP患者血清中抗PBP肽抗体升高,因此抗PBP血清抗体不是诊断AIP的有用工具。

研究设计与样本

  • 2007年3月至2011年5月连续收集1型AIP、胰腺导管腺癌(PDAC)、慢性胰腺炎(CP)、原发性硬化性胆管炎(PSC)及健康对照(HC)的血清。
  • 共检测114例:AIP 34例、PDAC 29例、CP 17例、PSC 16例、HC 18例(幽门螺杆菌阳性9例、阴性9例)。
  • 用ELISA法定量血清抗体与合成PBP肽的结合,以定制PBP兔多克隆抗体标准曲线,并设合成Flag肽(DYKDDDK)为阴性对照。

主要发现

  • PBP免疫兔血清选择性结合PBP肽而非Flag肽,证明PBP肽识别具有高敏感性。
  • 用PBP肽进行竞争实验验证了抗体识别该抗原的选择性。
  • 不同患者组与健康对照之间抗PBP肽抗体的检出无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Autoimmune pancreatitis (AIP) is a rare form of chronic pancreatitis, clinically mimicking pancreatic cancer. In 2009, a serological diagnostic test detecting antibodies against plasminogen-binding protein (PBP) of Helicobacter pylori was reported with outstanding test performances (NEJM 361:135). We aimed to validate these findings. METHODS: Between March 2007 and May 2011, sera were collected from consecutive patients presenting with type 1 AIP, pancreatic ductal adenocarcinoma (PDAC), chronic pancreatitis (CP), primary sclerosing cholangitis (PSC), and healthy controls (HC) with or without antibodies against H. pylori. Serum antibody binding to synthetic PBP peptide was quantified by enzyme-linked immunosorbent assay (ELISA), using standard curves of custom-made PBP rabbit polyclonal antibodies. A synthetic Flag peptide (DYKDDDK), to which no antibodies are found in human serum, was included as negative control. RESULTS: High sensitivity of PBP peptide recognition was demonstrated by selective binding of PBP peptide over Flag peptide by PBP-immunized rabbit serum. Competition assays with PBP peptide validated the selectivity for antibodies recognizing this antigen. A total of 114 patients were subsequently tested: 34 AIP, 29 PDAC, 17 CP, 16 PSC, and 18 HCs (9 positive and 9 negative for H. pylori). No significant differences in detection of antibodies against the PBP peptide were found between different the patient groups and healthy controls. CONCLUSIONS: Using a sensitive and selective ELISA-based assay, we did not find increased serum antibodies against PBP peptide in AIP patients. PBP serum antibodies are therefore not a useful diagnostic tool to diagnose AIP.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Buijs J, Cahen DL, van Heerde MJ, et al. Testing for Anti-PBP Antibody Is Not Useful in Diagnosing Autoimmune Pancreatitis. Am J Gastroenterol. 2016. PMID: 27325222. doi:10.1038/ajg.2016.241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。